Legacy Capital Partners Upped Freeport (FCX) Position By $340,000; Redwood Investments Trimmed Exelixis (EXEL) Position

June 22, 2018 - By Ellis Scott

Freeport-McMoRan Inc. (NYSE:FCX) Logo

Legacy Capital Partners Inc increased Freeport (FCX) stake by 98.14% reported in 2018Q1 SEC filing. Legacy Capital Partners Inc acquired 20,000 shares as Freeport (FCX)’s stock declined 12.54%. The Legacy Capital Partners Inc holds 40,380 shares with $709,000 value, up from 20,380 last quarter. Freeport now has $23.70B valuation. The stock increased 0.37% or $0.06 during the last trading session, reaching $16.36. About 12.19 million shares traded. Freeport-McMoRan Inc. (NYSE:FCX) has risen 45.98% since June 22, 2017 and is uptrending. It has outperformed by 33.41% the S&P500. Some Historical FCX News: 07/03/2018 – Texas Emissions: 279984 – BASF FREEPORT SITE; 15/05/2018 – FREEPORT SEES ADVANTAGES OF U.S. OVER LATAM AS IT WEIGHS OPPS; 02/04/2018 – Fidelity Select Gold Adds Freeport, Exits Beadell; 07/03/2018 – Freeport-McMoRan Says Copper Market Is Primed for Another Rally; 24/04/2018 – FREEPORT-MCMORAN INC QTRLY AVERAGE REALIZED PRICE PER POUND FOR COPPER WAS $3.11 VS $2.67 PER POUND REPORTED LAST YEAR; 24/04/2018 – FREEPORT EARMARKS CASHFLOW FOR DEBT, INVESTMENTS, SHAREHOLDERS; 22/05/2018 – RIO TINTO LTD RIO.AX – RIO TINTO CONFIRMS THAT DISCUSSIONS BETWEEN RIO TINTO, INALUM AND FREEPORT ARE ONGOING, INCLUDING AS TO PRICE; 07/05/2018 – INDONESIA’S INALUM CONSIDERING FURTHER MINING EXPLORATION IN PAPUA; 05/04/2018 – FREEPORT RESOURCES INC FRI.V SAYS MARTIN MACKINNON APPOINTED DIRECTOR; 25/05/2018 – FREEPORT-MCMORAN INC FCX.N : B.RILEY RAISES TARGET PRICE TO $20 FROM $17

Redwood Investments Llc decreased Exelixis Inc (EXEL) stake by 70.45% reported in 2018Q1 SEC filing. Redwood Investments Llc sold 74,774 shares as Exelixis Inc (EXEL)’s stock declined 29.43%. The Redwood Investments Llc holds 31,357 shares with $695,000 value, down from 106,131 last quarter. Exelixis Inc now has $6.04B valuation. The stock decreased 1.31% or $0.27 during the last trading session, reaching $20.36. About 2.11M shares traded. Exelixis, Inc. (NASDAQ:EXEL) has risen 6.49% since June 22, 2017 and is uptrending. It has underperformed by 6.08% the S&P500. Some Historical EXEL News: 28/03/2018 – EXELIXIS’ PARTNER IPSEN ANNOUNCES EMA VALIDATION OF THE APPLICATION FOR A NEW INDICATION FOR CABOMETYX® (CABOZANTINIB) FOR PREVIOUSLY TREATED ADVANCED HEPATOCELLULAR CARCINOMA; 10/05/2018 – GENENTECH- RESULTS FROM IMBLAZE370 SHOWED TREATMENT WITH TECENTRIQ ALONE DID NOT PROVIDE MEANINGFUL CLINICAL BENEFIT COMPARED TO REGORAFENIB; 08/05/2018 – Pain From Toys `R’ Us Liquidation Spreads to Hain Celestial; 08/05/2018 – Hain Celestial 3Q EPS 12c; 03/05/2018 – Exelixis at American Society of Clinical Oncology Meeting Jun 2; 24/05/2018 – Autodesk: celestial being; 18/04/2018 – Calithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 in Combination with Cabozantinib for Treatment of Patients with Advanced Renal Cell Carcinoma; 02/05/2018 – EXELIXIS & INVENRA ENTER INTO PACT TO DISCOVER & DEVELOP NOVEL; 08/05/2018 – HAIN CELESTIAL – SEES 2018 ADJ EPS $1.11 TO $1.18; 23/03/2018 – EXELIXIS INC EXEL.O – EXELIXIS IS ELIGIBLE TO RECEIVE A MILESTONE PAYMENT OF $50 MLN FOR APPROVAL OF FIRST-LINE TREATMENT OF ADVANCED RCC

Among 24 analysts covering Freeport-McMoran Copper & Gold (NYSE:FCX), 6 have Buy rating, 5 Sell and 13 Hold. Therefore 25% are positive. Freeport-McMoran Copper & Gold had 108 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Freeport-McMoRan Inc. (NYSE:FCX) earned “Buy” rating by Jefferies on Monday, August 28. The firm earned “Outperform” rating on Friday, July 24 by Cowen & Co. The stock of Freeport-McMoRan Inc. (NYSE:FCX) earned “Buy” rating by Deutsche Bank on Saturday, August 29. Barclays Capital maintained Freeport-McMoRan Inc. (NYSE:FCX) on Monday, May 2 with “Equal Weight” rating. BMO Capital Markets maintained the stock with “Hold” rating in Monday, December 18 report. UBS maintained the stock with “Neutral” rating in Tuesday, March 6 report. The firm has “Sell” rating by TheStreet given on Friday, August 28. The rating was maintained by Cowen & Co on Tuesday, April 24 with “Buy”. The stock has “Mkt Perform” rating by FBR Capital on Monday, May 1. Morgan Stanley downgraded the stock to “Underweight” rating in Wednesday, September 14 report.

Since January 31, 2018, it had 0 insider purchases, and 1 sale for $419,125 activity. On Wednesday, January 31 the insider WHITMIRE C DONALD JR sold $419,125.

Investors sentiment increased to 1.07 in 2018 Q1. Its up 0.15, from 0.92 in 2017Q4. It improved, as 36 investors sold FCX shares while 222 reduced holdings. 95 funds opened positions while 180 raised stakes. 1.00 billion shares or 1.38% more from 989.88 million shares in 2017Q4 were reported. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mngmt reported 1.01M shares stake. Da Davidson stated it has 210,089 shares or 0.08% of all its holdings. Envestnet Asset Management reported 105,626 shares. Nuveen Asset Ltd Liability Corporation holds 0.01% or 65,409 shares in its portfolio. Wesbanco State Bank accumulated 17,755 shares. Franklin Res has 0.06% invested in Freeport-McMoRan Inc. (NYSE:FCX). Berkshire Asset Ltd Pa stated it has 20,699 shares or 0.04% of all its holdings. Outfitter Advsr owns 10,650 shares or 0.09% of their US portfolio. Jump Trading Ltd Liability holds 0% of its portfolio in Freeport-McMoRan Inc. (NYSE:FCX) for 1,181 shares. Fisher Asset Mngmt Limited holds 43,319 shares. Canandaigua National Bank & Trust And Tru invested in 70,229 shares. Comml Bank Of Ny Mellon Corp reported 21.23M shares. Mackay Shields Ltd Liability has invested 0.24% of its portfolio in Freeport-McMoRan Inc. (NYSE:FCX). The New York-based Morgan Stanley has invested 0.02% in Freeport-McMoRan Inc. (NYSE:FCX). Blackrock Inc reported 90.05M shares.

More notable recent Freeport-McMoRan Inc. (NYSE:FCX) news were published by: Bizjournals.com which released: “Largest Arizona-based Public Companies” on June 22, 2018, also Seekingalpha.com with their article: “The Curious Case Of Freeport-McMoRan” published on June 11, 2018, Seekingalpha.com published: “Freeport-McMoRan: Strong Potential” on June 05, 2018. More interesting news about Freeport-McMoRan Inc. (NYSE:FCX) were released by: Fool.com and their article: “Is Freeport-McMoRan, Inc. a Buy?” published on June 18, 2018 as well as Seekingalpha.com‘s news article titled: “Freeport-McMoRan: Update On Bullish Thesis” with publication date: June 07, 2018.

Redwood Investments Llc increased Firstcash Inc stake by 26,661 shares to 320,400 valued at $26.03 million in 2018Q1. It also upped Allstate Corp (NYSE:ALL) stake by 25,995 shares and now owns 66,729 shares. Amn Healthcare Services Inc (NYSE:AHS) was raised too.

Among 11 analysts covering Exelixis (NASDAQ:EXEL), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Exelixis had 42 analyst reports since January 19, 2016 according to SRatingsIntel. On Tuesday, January 16 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Exelixis, Inc. (NASDAQ:EXEL) earned “Buy” rating by Needham on Monday, October 16. SunTrust initiated it with “Buy” rating and $3300 target in Thursday, July 13 report. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, September 7. Piper Jaffray maintained it with “Buy” rating and $29.0 target in Sunday, September 10 report. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, May 3. The stock of Exelixis, Inc. (NASDAQ:EXEL) earned “Buy” rating by Deutsche Bank on Thursday, November 3. The stock of Exelixis, Inc. (NASDAQ:EXEL) has “Outperform” rating given on Tuesday, January 19 by Leerink Swann. The firm has “Buy” rating by SunTrust given on Monday, January 22. The firm has “Buy” rating given on Wednesday, June 14 by William Blair.

More recent Exelixis, Inc. (NASDAQ:EXEL) news were published by: Seekingalpha.com which released: “Exelixis: Our Latest Take On This Oncology Concern” on June 18, 2018. Also Seekingalpha.com published the news titled: “An Integrated BioSci Research On Exelixis: What The Recent Talent Acquisition Foretells?” on June 04, 2018. Nasdaq.com‘s news article titled: “Consolidated Research: 2018 Summary Expectations for Rayonier Advanced Materials, CYS Investments, Avid …” with publication date: June 14, 2018 was also an interesting one.

Analysts await Exelixis, Inc. (NASDAQ:EXEL) to report earnings on August, 1. They expect $0.14 EPS, up 75.00% or $0.06 from last year’s $0.08 per share. EXEL’s profit will be $41.56 million for 36.36 P/E if the $0.14 EPS becomes a reality. After $0.37 actual EPS reported by Exelixis, Inc. for the previous quarter, Wall Street now forecasts -62.16% negative EPS growth.

Investors sentiment decreased to 1.16 in 2018 Q1. Its down 0.41, from 1.57 in 2017Q4. It dived, as 39 investors sold EXEL shares while 74 reduced holdings. 47 funds opened positions while 84 raised stakes. 225.93 million shares or 2.97% less from 232.85 million shares in 2017Q4 were reported. Caisse De Depot Et Placement Du Quebec has invested 0.03% in Exelixis, Inc. (NASDAQ:EXEL). Deutsche Natl Bank Ag has invested 0.02% in Exelixis, Inc. (NASDAQ:EXEL). Avalon Lc holds 0.06% of its portfolio in Exelixis, Inc. (NASDAQ:EXEL) for 90,755 shares. 142,304 are held by Qs Investors Limited Liability Company. Hudson Bay Management LP owns 30,000 shares. 26,300 are owned by Grantham Mayo Van Otterloo Co Lc. Sg Americas Secs Ltd Liability invested in 0% or 20,490 shares. Prelude Mngmt Lc owns 0% invested in Exelixis, Inc. (NASDAQ:EXEL) for 2,189 shares. Hudock Capital Gp Ltd Liability owns 0% invested in Exelixis, Inc. (NASDAQ:EXEL) for 100 shares. Massachusetts Finance Serv Company Ma has 0% invested in Exelixis, Inc. (NASDAQ:EXEL). Hightower Advisors Limited Liability, Illinois-based fund reported 32,920 shares. Dimensional Fund Advsr Ltd Partnership stated it has 1.04M shares. Ameriprise Fincl accumulated 183,987 shares. Great West Life Assurance Can holds 34,671 shares or 0% of its portfolio. 62,457 were reported by Sei Invs.

Since January 8, 2018, it had 0 insider buys, and 23 selling transactions for $14.66 million activity. Garber Alan M also sold $303,750 worth of Exelixis, Inc. (NASDAQ:EXEL) on Monday, April 16. Hessekiel Jeffrey had sold 65,000 shares worth $1.35 million on Thursday, May 31. $610,847 worth of stock was sold by Haley Patrick J. on Friday, May 4. Another trade for 15,000 shares valued at $332,250 was sold by PAPADOPOULOS STELIOS. Another trade for 22,500 shares valued at $519,417 was sold by Schwab Gisela. Shares for $1.07M were sold by WILLSEY LANCE on Tuesday, May 22. FELDBAUM CARL B sold 11,000 shares worth $262,680.

Exelixis, Inc. (NASDAQ:EXEL) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts